We help our clients in the healthcare industries
build value for their products using four essential steps
PHMR market access alerts
Our market access alerts are hand-picked items of breaking industry news. You can become a subscriber for free and receive these alerts direct to your inbox.
Our latest alerts direct to your inbox.
Just enter your email address below and we'll make sure you never miss out on a market access alert again.
Alternatively you can unsubscribe here.
- 25 Jul 2015 Help us tailor our market access alerts to you
- 23 Jul 2015 Cancer Taskforce recommends new strategy for tackling cancer in England and Mark Deverill to lead PHMR’s Newcastle team
- 17 Jul 2015 PHMR welcomes Mark Deverill to UK team and NICE recommends Entyvio for Crohn’s disease
- 8 Jul 2015 UK NHS data reveals poor rates of cancer survival and ASCO publishes framework to assess value of new cancer treatments
- 22 Jun 2015 PHMR presents poster on PFS2 at HTAi Oslo and ABPI welcomes focus on medicines optimisation in recent DoH report
- 18 May 2015 WHO release latest World Health Statistics and SMC recommends Takeda’s Entyvio for ulcerative colitis
- 11 May 2015 ABPI study shows clinical trial disclosure rate improves and EMA updates rules on declarations of interests
- 1 May 2015 King’s Fund report reveals NHS performance and 11 new medicines receive CHMP recommendation for EU approval
- 24 Apr 2015 Novartis’ heart failure medicine takes first step towards early access and EMA scientific advice leads to stronger applications
- 17 Apr 2015 WHO calls for disclosure of previously unreported clinical trials, and NIHR Horizon Scanning Centre’s latest briefings on cancer